Darby Andrew E
Assistant Professor, University of Virginia, Charlottesville, VA.
J Atr Fibrillation. 2016 Jun 30;9(1):1427. doi: 10.4022/jafib.1427. eCollection 2016 Jun-Jul.
Recurrent AF after catheter ablation occurs in at least 20 to 40% of patients. Repeat ablation is primarily considered for those with symptomatic AF recurrences (often drug-refactory) occurring at least 3 months or more post-ablation. Pulmonary vein reconnection is almost universally encountered, and repeat isolation of electrically connected pulmonary veins should be the primary ablation strategy. Beyond repeat PVI and possible ablation of non-PV triggers, there is little to no evidence that additional substrate modification improves outcomes. In addition to repeat ablation, it is critical to address and treat comorbid conditions which increase arrhythmia risk post-ablation. Specifically, obesity, hypertension, and sleep-disordered breathing should be targeted and modified to increase the likelihood of success.
导管消融术后房颤复发至少发生在20%至40%的患者中。重复消融主要针对那些在消融后至少3个月或更长时间出现症状性房颤复发(通常对药物难治)的患者。几乎普遍会遇到肺静脉重新连接的情况,重复隔离电连接的肺静脉应作为主要的消融策略。除了重复肺静脉隔离术以及可能对非肺静脉触发灶进行消融外,几乎没有证据表明额外的基质改良能改善预后。除了重复消融外,处理和治疗增加消融后心律失常风险的合并症至关重要。具体而言,应针对肥胖、高血压和睡眠呼吸紊乱进行干预和改善,以提高成功的可能性。